BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17883042)

  • 1. The role of sentinel lymph node biopsy in the management of breast cancer.
    Khan A; Vohra P; Quinlan RF
    Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
    Catzeddu T; Bertelli G; Del Mastro L; Venturini M
    J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
    Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D
    Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
    Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
    Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.
    Menard JP; Extra JM; Jacquemier J; Buttarelli M; Lambaudie E; Bannier M; Brenot Rossi I; Houvenaeghel G
    Eur J Surg Oncol; 2009 Sep; 35(9):916-20. PubMed ID: 19157769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.
    Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H
    Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer.
    Papa MZ; Zippel D; Kaufman B; Shimon-Paluch S; Yosepovich A; Oberman B; Sadetzki S
    J Surg Oncol; 2008 Nov; 98(6):403-6. PubMed ID: 18683193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of sentinel lymph node biopsy in early breast cancer.
    Jatoi I
    Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
    Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
    Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The sentinel lymph node in cancer of the breast: clinical aspects].
    Rouzier R; Travagli JP; Atallah D; Delaloge S; Marsiglia H; Mathieu MC; Lumbroso J; Garbay JR
    Bull Cancer; 2003 Mar; 90(3):246-54. PubMed ID: 12801827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.